Avacta appoints new chief scientific officer, plans clinical trials
(Alliance News) - Avacta Group PLC on Monday said it has promoted Francis Wilson to chief scientific officer. Read More
| Price | 57.00p on 13-02-2026 at 19:40:05 |
|---|---|
| Change | -0.50p -0.85% |
| Buy | 58.00p |
| Sell | 56.00p |
| Last Trade: | Buy 9,000.00 at 58.00p |
| Day's Volume: | 678,529 |
| Last Close: | 58.00p |
| Open: | 58.50p |
| ISIN: | GB00BYYW9G87 |
| Day's Range | 58.00p - 58.00p |
| 52wk Range: | 27.25p - 83.20p |
| Market Capitalisation: | £253.83m |
| VWAP: | 57.52778p |
| Shares in Issue: | 437.63m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Avacta Group (AVCT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 9,000 | 58.00p | Suspected BUY Trade |
16:35:27 - 13-Feb-26 |
| Sell* | 409 | 56.661p | Ordinary |
16:28:06 - 13-Feb-26 |
| Buy* | 20,000 | 57.299p | Ordinary |
16:24:21 - 13-Feb-26 |
| Buy* | 2,029 | 57.299p | Ordinary |
16:23:35 - 13-Feb-26 |
| Buy* | 8,719 | 57.2961p | Ordinary |
16:20:54 - 13-Feb-26 |
| Sell* | 303 | 56.00p | Ordinary |
16:19:13 - 13-Feb-26 |
| Buy* | 5,235 | 57.299p | Ordinary |
16:15:10 - 13-Feb-26 |
| Sell* | 5,000 | 56.4125p | Ordinary |
16:09:54 - 13-Feb-26 |
| Sell* | 10,000 | 56.4001p | Ordinary |
16:08:16 - 13-Feb-26 |
| Sell* | 2,000 | 56.3778p | Ordinary |
16:01:54 - 13-Feb-26 |
Avacta Group (AVCT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Feb 2026 7:00 am | RNS | Appointment of CSO |
| 3rd Feb 2026 7:00 am | RNS | Faridoxorubicin Program Clinical Updates |
| 21st Jan 2026 7:00 am | RNS | FDA Clearance of IND Application for AVA6103 |
| 20th Jan 2026 7:01 am | RNS | Year-end trading update |
| 20th Jan 2026 7:00 am | RNS | Appointment of Nominated Adviser & TVR |
| 18th Dec 2025 7:00 am | RNS-R | Avacta reports new AVA6103 pharmacology data |
| 17th Dec 2025 7:00 am | RNS | Faridoxorubicin Phase 1b SGC data |
| 8th Dec 2025 7:00 am | RNS | Preliminary Data in Faridoxorubicin Phase 1b Trial |
| 3rd Nov 2025 8:24 am | RNS | Completion of Placing and TVR |
| 27th Oct 2025 5:39 pm | RNS | Block Listing Six Monthly Return |